Albemarle Corporation (NYSE:ALB - Get Free Report)'s stock price gapped down before the market opened on Monday. The stock had previously closed at $101.27, but opened at $97.00. Albemarle shares last traded at $97.3470, with a volume of 470,037 shares.
Wall Street Analyst Weigh In
ALB has been the topic of several research reports. Zacks Research downgraded Albemarle from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 20th. Mizuho dropped their price target on Albemarle from $140.00 to $130.00 and set a "neutral" rating for the company in a research report on Thursday, October 1st. Citigroup reduced their price objective on Albemarle from $225.00 to $175.00 and set a "buy" rating for the company in a research note on Friday, August 7th. Rothschild & Co Redburn reduced their price objective on Albemarle from $188.00 to $170.00 and set a "neutral" rating for the company in a research note on Wednesday, July 1st. Finally, Royal Bank Of Canada decreased their price objective on Albemarle from $166.00 to $157.00 and set an "outperform" rating on the stock in a report on Monday, August 10th. Fifteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $185.27.
Read Our Latest Analysis on Albemarle
Albemarle Stock Performance
The company has a market cap of $11.60 billion, a PE ratio of 363.98, a PEG ratio of 0.60 and a beta of 1.36. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.35 and a current ratio of 2.09. The firm's 50 day moving average is $121.89 and its 200-day moving average is $148.32.
Albemarle (NYSE:ALB - Get Free Report) last released its earnings results on Wednesday, August 5th. The specialty chemicals company reported $3.75 earnings per share for the quarter, topping analysts' consensus estimates of $3.20 by $0.55. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.61 billion. Albemarle had a net margin of 3.09% and a return on equity of 10.96%. The business's revenue was up 31.1% on a year-over-year basis. During the same period last year, the company posted $0.11 EPS. On average, research analysts anticipate that Albemarle Corporation will post 11.25 earnings per share for the current fiscal year.
Albemarle Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Friday, September 11th were given a dividend of $0.41 per share. The ex-dividend date was Friday, September 11th. This is a positive change from Albemarle's previous quarterly dividend of $0.4050. This represents a $1.64 dividend on an annualized basis and a yield of 1.7%. Albemarle's dividend payout ratio (DPR) is 607.41%.
Hedge Funds Weigh In On Albemarle
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Addison Advisors LLC acquired a new position in shares of Albemarle during the second quarter worth about $28,000. Sound Income Strategies LLC raised its holdings in Albemarle by 190.1% in the first quarter. Sound Income Strategies LLC now owns 293 shares of the specialty chemicals company's stock valued at $52,000 after acquiring an additional 192 shares in the last quarter. Dakota Community Bank & Trust NA acquired a new stake in Albemarle in the first quarter valued at approximately $54,000. Fiduciary Financial Advisors acquired a new stake in Albemarle in the second quarter valued at approximately $41,000. Finally, Jones Financial Companies Lllp purchased a new position in Albemarle in the second quarter worth approximately $42,000. Institutional investors and hedge funds own 92.87% of the company's stock.
About Albemarle
(
Get Free Report)
Albemarle Corporation NYSE: ALB is a global specialty chemicals company that develops, manufactures and markets materials used in energy storage, transportation, consumer products and industrial applications. The company is best known for its lithium business, which supplies lithium compounds used in rechargeable batteries for electric vehicles, portable electronics and energy-storage systems.
Albemarle also produces bromine-based specialty chemicals used in areas such as fire safety, water treatment, pharmaceutical manufacturing and other industrial processes.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.